Barclays analyst Alex Sloane maintained a Buy rating on Glanbia (GLAPF – Research Report) today and set a price target of €16.50. See what stocks are receiving Strong Buy ratings from top ...
Barclays lowered the firm’s price target on Glanbia (GLAPF) to EUR 16.50 from EUR 17.50 and keeps an Overweight rating on the shares. See what stocks are receiving Strong Buy ratings from top ...
Shares in Irish food group Glanbia plummeted by over 23 per cent on Wednesday after the company said it expected earnings to fall by up to 11 per cent this year. Its shares closed at €11.20 on ...
Shares down sharply on warning that high-end whey costs will hit the bottom line this year Glanbia Chief Executive Hugh McGuire Irish stock market-listed food giant Glanbia lost almost a quarter ...
Shares in global nutrition group Glanbia sank by over 20% today after it warned that it expects earnings to fall by up to 11% this year, hit by a longer than expected rise in the cost of whey ...
Shares in Glanbia took its largest plunge since 2007 as the food group warned that a global tariff war could impact its ability to source raw materials and deliver products. Concerns over rising ...
A shake for breakfast, a shake for lunch and a sensible dinner. That was SlimFast’s pitch to consumers in the 1980s and 1990s. It was a hit. The simple idea was that you could lose weight by ...
DUBLIN, Feb 26 (Reuters) - Nutrition supplement maker Glanbia will sell its underperforming U.S. weight management brand SlimFast as part of a wider plan targeting annual cost savings of at least ...
Like Queen Elizabeth, she loves horses and a great tiara moment. Meghan Markle's refreshed lifestyle brand has a logo with a meaningful symbol. On Feb. 18, the Duchess of Sussex announced that she ...
Just like the brand’s logo, the brand’s name is full of meaning, too. In an Instagram video, Meghan explained, “As Ever essentially means ‘as it’s always been,’ and if you’ve ...
Hosted on MSN21d
Supplements producer Glanbia's shares dive on profit warningDUBLIN (Reuters) - Shares in nutrition supplement maker Glanbia slid by 15% on Wednesday after it warned that it expects earnings to fall by up to 11% this year, hit by a longer than expected rise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results